CASC3 and Miyoshi myopathy: Moreover, SCFSkp2 is upregulated in BTZ-resistant MM and promotes the degradation of p27Kip1, which inhibits cyclin-dependent kinase, indicating that SCFSkp2 is another biomarker of BTZ resistance [22].